medroxyprogesterone has been researched along with Fibroid in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (25.00) | 18.7374 |
1990's | 8 (40.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Baird, DD; Cooper, TE; Harmon, QE; Patchel, SA; Umbach, DM; Zhao, S | 1 |
Johnson-Arbor, K; Verstraete, R | 1 |
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
Cuellar-Rodriguez, J; Merideth, M; Purisch, SE; Shanis, D; Stratton, P; Zerbe, C | 1 |
Hsu, SC; Kuo, CH; Lee, JN; Tsai, EM; Yang, CH | 1 |
Imai, S; Motegi, M; Nakajima, T; Sando, Y; Suzuki, T; Takayanagi, N; Ubukata, M; Yoshida, I | 1 |
Barillaro, F; Bazzoffi, R; Capri, O; Critelli, C; Galoppi, P; Perrone, G; Zichella, L | 1 |
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G | 1 |
Di Carlo, C; Mastrantonio, P; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
Diedrich, K; Naether, O | 1 |
Baird, DT; Lumsden, MA; West, CP | 1 |
Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
Brooks, PG; Serden, SP | 1 |
Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
Barbieri, RL | 1 |
Friedman, AJ | 1 |
Barbieri, RL; Doubilet, PM; Fine, C; Friedman, AJ; Schiff, I | 1 |
Goldzieher, JW; Poindexter, AN | 1 |
Tiltman, AJ | 1 |
Candotti, G; Goisis, M | 1 |
2 review(s) available for medroxyprogesterone and Fibroid
Article | Year |
---|---|
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
5 trial(s) available for medroxyprogesterone and Fibroid
Article | Year |
---|---|
[Effect of GnRH analogues on bone density in the vertebral column and the femur].
Topics: Adult; Age Factors; Antineoplastic Agents, Hormonal; Bone Density; Female; Femur; Femur Neck; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Lumbar Vertebrae; Medroxyprogesterone; Menstrual Cycle; Premenopause; Progesterone Congeners; Uterine Neoplasms | 1995 |
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
Topics: Administration, Cutaneous; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Norpregnenes; Progesterone Congeners; Treatment Outcome; Uterine Neoplasms | 2000 |
Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas.
Topics: Administration, Cutaneous; Administration, Oral; Calcium Carbonate; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Postmenopause; Treatment Outcome; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2001 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri.
Topics: Adult; Antineoplastic Agents; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Uterine Neoplasms | 1988 |
13 other study(ies) available for medroxyprogesterone and Fibroid
Article | Year |
---|---|
Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma.
Topics: Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Incidence; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate | 2022 |
No Bad Blood-Surviving Severe Anemia Without Transfusion.
Topics: Anemia; Bloodless Medical and Surgical Procedures; Female; Ferric Compounds; Hematinics; Humans; Hyperbaric Oxygenation; Infusions, Intravenous; Jehovah's Witnesses; Leiomyoma; Medroxyprogesterone; Middle Aged; Patient-Centered Care; Uterine Hemorrhage; Uterine Neoplasms | 2021 |
Management of uterine bleeding during hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptives, Oral, Synthetic; Estrogens; Female; GATA2 Transcription Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Induction Chemotherapy; Leiomyoma; Leuprolide; Medroxyprogesterone; Menorrhagia; Stroke; Uterine Balloon Tamponade; Uterine Neoplasms | 2013 |
Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
Topics: Adult; Analysis of Variance; Case-Control Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Leiomyoma; Medroxyprogesterone; Middle Aged; Postmenopause; Progesterone Congeners; Prospective Studies; Ultrasonography; Uterine Neoplasms | 2002 |
[A case of so-called benign metastasizing leiomyoma responsive to progesterone].
Topics: Female; Humans; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Medroxyprogesterone; Middle Aged; Remission Induction; Uterine Neoplasms | 1993 |
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
Topics: Bone and Bones; Climacteric; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Ultrasonography; Uterine Neoplasms; Uterus | 1989 |
Medical aspects of contraception.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone; Risk; Uterine Neoplasms | 1987 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
[Gynecological indications of a new progestational agent with prolonged action].
Topics: Abortion, Threatened; Adenocarcinoma; Adolescent; Adult; Breast Neoplasms; Delayed-Action Preparations; Endometriosis; Female; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Leiomyoma; Medroxyprogesterone; Menstruation Disturbances; Middle Aged; Pregnancy; Tuberculosis, Female Genital; Uterine Cervical Neoplasms; Uterine Neoplasms | 1970 |